Download this practical tool ‘Know Your Number’ to help you keep track of the important factors/screen tests needed to manage your autoimmune condition and ensure the best possible health. Click here


We're here to help

Welcome to the Dragon Claw website where you’ll find a wealth of information and support for those affected by Rheumatoid Disease, Lupus and JIA.  Dragon Claw exists to help you better manage your health and get the support you need to live to the fullest.

In 2022 we expanded our support to all of those with AUTOIMMUNE IMFLAMMATORY DISEASES. There are numerous types of diseases in 3 groups being Rheumatology, Dermatology and Gastroenterology.

We strongly believe in an integrated and holistic approach to managing these diseases so we have brought together practical information, personal stories, dietary advice and hints and tips to help you when you are thinking about how to manage your condition and lifestyle.
Just browse through the ‘Here to Help' section to discover the sort of information that's available.

Listen to Susan’s story about her experience with Rheumatoid Arthritis and why you should become a member of Dragon Claw.



Inviting you to Dragon Talks

Weekly one-hour zoom teleconference providing information, discussion and support
for those affected by autoimmunity (patients or companions)
Hear what our regular members have to say about Dragon Talks Play Here


Help me find



Become a Member today

The site you are currently looking at is the public site but if you register as a member you’ll have access to even more invaluable resources that include

Video Library

Over 60 short videos across a whole range of topics including exercise advice, interviews with sufferers and diet and nutrition information

Members Forum

Where you’ll be able to discuss and learn more about your disease with other sufferers and carers. Over 30 topics have been covered already

Literature Central

Packed with the latest research and information.

Dragon Claw is not just for sufferers. If you care for someone with rheumatoid disease or lupus then you're most welcome.  Or perhaps you are a clinician then Dragon Claw can help you to support your patients.

To find out more about what is available as a member of Dragon Claw simply click here to take a tour of the Members site.


Register Today. It's free



 or Watch our Welcome Video




Crippling RA is rampant amongst First Australians

On a recent visit to remote indigenous communities Dragon Claw saw that there was an urgent need to help local first Australian suffers of these diseases as many did not fully appreciate the importance of taking their medication on a regular basis.

Dragon Claw was determined to address this issue and decided to launch the world’s first educational pilot program to remote first nations peoples anywhere in the world specifically on RA.
This video gives you an insight into some of the issues associated RA and Lupus for First Australian and how these videos were developed.


RA and Lupus Amongst Australian Indigenous Populations

Watch Jill’s 2 minute video as she tells her story

A lifetime nursing very sick hospital patients required high energy and activity on her feet, a role she loved and lived for.  Her diagnosis prematurely ended this and led her to a dark place of pain and discomfort until she found the Dragon Talk Forum. Please


Does emotional health impact pain in rheumatoid arthritis?

Quoted from Medivizor

In a nutshell

This study investigated if emotional health affects pain in patients with rheumatoid arthritis (RA). They found that emotional health, along with physical state can have an effect on pain in RA. 

Some background

Rheumatoid arthritis (RA) is a long-term condition. It leads to painful swelling and inflammation in the joints. As RA progresses, tissue in the joints will get damaged. This leads to persistent pain.



JOIN and get access to the Video Library and Literature Central which more than doubles the size of the public website. 

New RA Biologic Approved by the USA

RINVOQ is for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or